3Cnet: pathogenicity prediction of human variants using multitask learning with evolutionary constraints.


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
11 12 2021
Historique:
received: 02 02 2021
revised: 05 07 2021
accepted: 15 07 2021
medline: 13 4 2023
pubmed: 17 7 2021
entrez: 16 7 2021
Statut: ppublish

Résumé

Improvements in next-generation sequencing have enabled genome-based diagnosis for patients with genetic diseases. However, accurate interpretation of human variants requires knowledge from a number of clinical cases. In addition, manual analysis of each variant detected in a patient's genome requires enormous time and effort. To reduce the cost of diagnosis, various computational tools have been developed to predict the pathogenicity of human variants, but the shortage and bias of available clinical data can lead to overfitting of algorithms. We developed a pathogenicity predictor, 3Cnet, that uses recurrent neural networks to analyze the amino acid context of human variants. As 3Cnet is trained on simulated variants reflecting evolutionary conservation and clinical data, it can find disease-causing variants in patient genomes with 2.2 times greater sensitivity than currently available tools, more effectively discovering pathogenic variants and thereby improving diagnosis rates. Codes (https://github.com/KyoungYeulLee/3Cnet/) and data (https://zenodo.org/record/4716879#.YIO-xqkzZH1) are freely available to non-commercial users. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 34270679
pii: 6322986
doi: 10.1093/bioinformatics/btab529
pmc: PMC8665754
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4626-4634

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Auteurs

Dhong-Gun Won (DG)

Research and Development Center, 3billion, Seoul 06193, Republic of Korea.

Dong-Wook Kim (DW)

Research and Development Center, 3billion, Seoul 06193, Republic of Korea.

Junwoo Woo (J)

Research and Development Center, 3billion, Seoul 06193, Republic of Korea.

Kyoungyeul Lee (K)

Research and Development Center, 3billion, Seoul 06193, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH